One-glance verdict
Not enough data
Fair value unavailable
Not enough cash-flow history to value this one with our method.
Fundamentals snapshot
Quanterix Corporation
QTRX · NGM · Healthcare · Medical Devices
Current price
$3.12
52-week range
$2.15 - $8.77
Market cap
$147.55M
Balance sheet
Healthy
-12.82x Concerning
Net cash $60.14M. Interest coverage shows how many times profit covers the interest bill.
What stands out
1 Reward
1 Risk
1 rewards · 1 risks
- Reward Revenue grew 10.4% last year.
- Risk Return on equity was -46.5% last year — the company lost money on shareholders' equity.
What this company does
Quanterix Corporation
Quanterix Corporation sells special machines and tests that help scientists and doctors understand and measure tiny amounts of proteins in blood or other samples, mainly for research in areas like brain health, cancer, and immune diseases. Their money primarily comes from selling these instruments and the tests that run on them, which is important because it shows how much demand there is for their advanced diagnostic tools. This lets researchers get more precise results than older methods, helping them discover new treatments and understand diseases better.
Price history
How the share price has moved
—
Loading price history…
Earnings history
Last 8 quarters — what happened
Click any quarter to read the call summary and what the numbers say.
FY2024 Q3
$-6.60M
FY2024 Q4
$-4.71M
FY2025 Q1
$-15.14M
FY2025 Q2
$-6.43M
FY2025 Q3
$-41.93M
FY2025 Q4
$-16.54M
FY2026 Q1
$-18.19M
FY2026 Q2
$-5.21M
Revenue
$32.91M
Net income
$-48.93M
Diluted EPS
-1.04
Operating cash flow
$-5.12M
Free cash flow
$-5.21M
Fetching…
Sources
Revenue
$36.41M
Net income
$-17.54M
Diluted EPS
-0.37
Operating cash flow
$-18.11M
Free cash flow
$-18.19M
Fetching…
Sources
Revenue
$43.85M
Net income
$-23.12M
Diluted EPS
-0.48
Operating cash flow
$-16.44M
Free cash flow
$-16.54M
Fetching…
Sources
Revenue
$40.23M
Net income
$-33.52M
Diluted EPS
-0.73
Operating cash flow
$-41.25M
Free cash flow
$-41.93M
Fetching…
Sources
Revenue
$24.48M
Net income
$-30.01M
Diluted EPS
-0.77
Operating cash flow
$-5.66M
Free cash flow
$-6.43M
Fetching…
Sources
Revenue
$30.33M
Net income
$-20.50M
Diluted EPS
-0.53
Operating cash flow
$-13.89M
Free cash flow
$-15.14M
Fetching…
Sources
Revenue
$35.16M
Net income
$-10.63M
Diluted EPS
-0.27
Operating cash flow
$-4.30M
Free cash flow
$-4.71M
Fetching…
Sources
Revenue
$35.81M
Net income
$-8.35M
Diluted EPS
-0.22
Operating cash flow
$-5.75M
Free cash flow
$-6.60M
Fetching…
Sources
Is it cheap or expensive?
Fair value — vs current price $3.12
We couldn't calculate a fair value right now.
Is it drowning in debt?
Healthy
Net cash $60.1M - more cash than debt. Interest coverage -12.8x.
Net debt
$-60.14M
Interest coverage
-12.82x
Quanterix Corporation is healthier than 0 of 1 peers on balance-sheet leverage.
Healthy
Worse cushion
Baseline
Better cushion
QTRX
BASELINE
Quanterix Corporation
Total debt $33.39M Interest coverage -12.82x This is the baseline the peer rows are being compared against.
What you should know
The case for and against QTRX
1 Reward
1 Risk
Rewards
-
Revenue grew 10.4% last year.
Risks
-
Return on equity was -46.5% last year — the company lost money on shareholders' equity.
The numbers
All the key metrics, grouped by purpose
Tap any ? icon to learn what it means.
Valuation
How expensive the stock looks
P/E (TTM)
—
Forward P/E
-2.29x
P/B
0.62x
P/S
0.96x
EV/EBITDA
-1.24x
PEG ratio
—
Profitability
How much profit each dollar creates
Gross margin
44.6%
Operating margin
-68.4%
Net margin
-80.2%
ROE
-46.5%
ROA
-16.7%
Health
Liquidity and balance-sheet strength
Debt / equity
0.14x
Current ratio
3.40x
Quick ratio
2.30x
Total debt
$33.39M
Total cash
$93.53M
Growth
How the business has been compounding
Revenue TTM
$153.41M
Revenue 5Y CAGR
5.9%
EPS TTM
-2.61
EPS 5Y CAGR
—
Cash flow
How much cash the business throws off
Operating CF TTM
$-80.92M
Free CF TTM
$-79.85M
FCF margin
-52.0%
Dividend
Shareholder payout
Yield
0.0%
Payout ratio
—
Last ex-div date
—